tiprankstipranks
Aurobindo Pharma Ltd (IN:AUROPHARMA)
:AUROPHARMA
India Market

Aurobindo Pharma Ltd (AUROPHARMA) Financial Statements

Compare
0 Followers

Aurobindo Pharma Ltd Financial Overview

Aurobindo Pharma Ltd's market cap is currently ₹647.86B. The company's EPS TTM is ₹59.833; its P/E ratio is 18.64; and it has a dividend yield of 0.42%. Aurobindo Pharma Ltd is scheduled to report earnings on February 14, 2025, and the estimated EPS forecast is ₹17.09. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Mar 23Mar 22Mar 21Mar 20
Income Statement
Total Revenue₹ 290.02B₹ 246.17B₹ 233.67B₹ 245.58B₹ 227.38B
Gross Profit₹ 160.16B₹ 133.24B₹ 132.26B₹ 146.55B₹ 130.03B
Operating Income₹ 104.50B₹ 25.51B₹ 33.06B₹ 44.54B₹ 39.40B
EBITDA₹ 61.79B₹ 40.09B₹ 45.79B₹ 85.29B₹ 48.85B
Net Income₹ 31.73B₹ 19.27B₹ 26.48B₹ 53.35B₹ 28.45B
Balance Sheet
Cash & Short-Term Investments₹ 63.25B₹ 65.26B₹ 45.58B₹ 56.21B₹ 28.42B
Total Assets₹ 450.72B₹ 398.90B₹ 339.22B₹ 338.54B₹ 289.26B
Total Debt₹ 66.48B₹ 52.86B₹ 32.79B₹ 55.50B₹ 63.01B
Net Debt₹ 32.54B₹ 8.90B₹ -8.84B₹ 1.76B₹ 35.38B
Total Liabilities₹ 152.21B₹ 130.38B₹ 93.48B₹ 119.25B₹ 121.16B
Stockholders' Equity₹ 298.43B₹ 268.40B₹ 245.76B₹ 219.30B₹ 168.10B
Cash Flow
Free Cash Flow₹ -11.27B₹ -3.34B₹ 23.12B₹ 14.55B₹ 29.50B
Operating Cash Flow₹ 24.35B₹ 23.87B₹ 50.16B₹ 33.29B₹ 43.81B
Investing Cash Flow₹ -45.37B₹ -39.78B₹ -32.12B₹ 5.99B₹ -15.68B
Financing Cash Flow₹ 8.00B₹ 18.14B₹ -29.69B₹ -13.65B₹ -19.47B
Currency in INR

Aurobindo Pharma Ltd Earnings and Revenue History

Aurobindo Pharma Ltd Debt to Assets

Aurobindo Pharma Ltd Cash Flow

Aurobindo Pharma Ltd Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis